Plain-English translation of NCT07167550 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help people recover better after an ischemic stroke (a stroke caused by a blood clot). Half of the participants will receive the new medication through an IV, and half will receive a placebo (a non-active treatment that looks the same). The study wants to find out if this medication is safe and effective at improving how well people recover.
After an ischemic stroke, time is critical—but there are limited treatment options available in the days and weeks following the stroke. Researchers believe this medication might help reduce brain damage and improve recovery, and this trial will test whether it actually works.
You likely qualify if…
You likely don't qualify if…
You will visit the study site multiple times over about two weeks. During the first three days, you'll receive the medication (or placebo) through an IV infusion three times per day. From days 4 to 14, you'll continue receiving the treatment three times daily in a smaller volume form. The researchers will use standardized tests to measure your neurological recovery and check how you're doing. The entire study, including screening and follow-up visits, will take about two weeks.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Russia